Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Name: Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
Published: 2026
License: Public Domain

Gyala Therapeutics · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

cell-therapy gene-therapy leukemia t-cell

acute myeloblastic leukaemia, leukemia, t-cell, cart84, cart, aml, t-all, cd84, car-t, cell therapy, gene therapy, gya01, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Related documents